4-氰基-呋喃-2-甲酸甲酯 | 357289-65-7

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 呋喃
• 中文名称: 4-氰基-呋喃-2-甲酸甲酯
• 中文别名: 4-氰基-2-呋喃羧酸甲酯(9ci)
• 英文名称: methyl 4-cyanofuran-2-carboxylate
• 英文别名: 4-cyano-furan-2-carboxylic acid methyl ester
• CAS: 357289-65-7
• 化学式: C₇H₅NO₃
• 分子量: 151.122
• InChiKey: UHMAJZKPNPNPHW-UHFFFAOYSA-N

物化性质

• 沸点：
  264℃
• 密度：
  1.27
• 闪点：
  114℃

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  63.2
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 海关编码：
  2932190090
• 危险性防范说明：
  P264,P280,P302+P352,P305+P351+P338,P332+P313,P337+P313,P362
• 危险性描述：
  H315,H319
• 储存条件：
  2-8°C

反应信息

• 作为反应物：
  描述：

  4-氰基-呋喃-2-甲酸甲酯 在 硼氘化钠 、 nickel(II) chloride hexahydrate 、 lithium hydroxide monohydrate 作用下， 以 甲醇 、 水 为溶剂， 反应 2.0h， 生成 4-((tert-butoxycarbonyl)amino(²H₂₎methyl)furan-2-carboxylic acid
  参考文献：
  名称：

  Synthesis and evaluation of novel heteroaromatic substrates of GABA aminotransferase

  摘要：

  Two principal neurotransmitters are involved in the regulation of mammalian neuronal activity, namely, gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter, and L-glutamic acid, an excitatory neurotransmitter. Low GABA levels in the brain have been implicated in epilepsy and several other neurological diseases. Because of GABA's poor ability to cross the blood-brain barrier (BBB), a successful strategy to raise brain GABA concentrations is the use of a compound that does cross the BBB and inhibits or inactivates GABA aminotransferase (GABA-AT), the enzyme responsible for GABA catabolism. Vigabatrin, a mechanism-based inactivator of GABA-AT, is currently a successful therapeutic for epilepsy, but has harmful side effects, leaving a need for improved GABA-AT inactivators. Here, we report the synthesis and evaluation of a series of heteroaromatic GABA analogues as substrates of GABA-AT, which will be used as the basis for the design of novel enzyme inactivators. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2012.08.009
• 作为产物：
  描述：

  4,5-二溴-2-糠酸 在 ammonium hydroxide 、 四(三苯基膦)钯 、 硫酸 、 锌 作用下， 以 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 生成 4-氰基-呋喃-2-甲酸甲酯
  参考文献：
  名称：

  Synthesis and evaluation of novel heteroaromatic substrates of GABA aminotransferase

  摘要：

  Two principal neurotransmitters are involved in the regulation of mammalian neuronal activity, namely, gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter, and L-glutamic acid, an excitatory neurotransmitter. Low GABA levels in the brain have been implicated in epilepsy and several other neurological diseases. Because of GABA's poor ability to cross the blood-brain barrier (BBB), a successful strategy to raise brain GABA concentrations is the use of a compound that does cross the BBB and inhibits or inactivates GABA aminotransferase (GABA-AT), the enzyme responsible for GABA catabolism. Vigabatrin, a mechanism-based inactivator of GABA-AT, is currently a successful therapeutic for epilepsy, but has harmful side effects, leaving a need for improved GABA-AT inactivators. Here, we report the synthesis and evaluation of a series of heteroaromatic GABA analogues as substrates of GABA-AT, which will be used as the basis for the design of novel enzyme inactivators. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2012.08.009

文献信息

• Adenosine receptor ligands and their use in the treatment of disease
  申请人：——

  公开号：US20010027196A1

  公开（公告）日：2001-10-04

  The invention relates to cyclic heteroaromatic compounds, containing at least one nitrogen atom, and to their use in the manufacture of medicaments for the treatment of diseases, related to adenosine receptor modulators, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain, respiration deficits, depression, asthma, allergic responses, hypoxia, ischaemia, seizure, substance abuse, sedation and they may be active as muscle relaxants, antipsychotics, anti epileptics, anticonvulsants and cardiaprotective agents.

  这项发明涉及含有至少一个氮原子的环状杂芳化合物，以及它们在制造用于治疗与腺苷受体调节剂相关的疾病的药物中的应用，如阿尔茨海默病、帕金森病、神经保护、精神分裂症、焦虑、疼痛、呼吸功能障碍、抑郁症、哮喘、过敏反应、缺氧、缺血、癫痫、物质滥用、镇静，它们可能作为肌肉松弛剂、抗精神病药、抗癫痫药、抗惊厥药和心脏保护剂而具有活性。
• Ligand-Promoted Rosenmund–von Braun Reaction
  作者：Dawei Ma、Quan Zhang

  DOI：10.1055/s-0042-1751414

  日期：——

  accelerating effect to classical Rosenmund–von Braun reaction, making the coupling of (hetero)aryl bromides with CuCN occur at 100–120 °C with good to excellent yields in most cases. A large number of functional groups and heterocycles were tolerated under these conditions, thereby providing a convenient and reliable approach for diverse synthesis of aryl nitriles.

  发现两种吡啶甲酰胺配体对经典的 Rosenmund-von Braun 反应具有显着的加速作用，使得（杂）芳基溴化物与 CuCN 的偶联发生在 100-120 °C，在大多数情况下具有良好至优异的产率。在这些条件下可以容忍大量的官能团和杂环，从而为芳基腈的多样化合成提供了一种方便可靠的方法。
• ADENOSINE RECEPTOR MODULATORS
  申请人：F.HOFFMANN-LA ROCHE AG

  公开号：EP1261327A2

  公开（公告）日：2002-12-04
• US6586441B2
  申请人：——

  公开号：US6586441B2

  公开（公告）日：2003-07-01
• [EN] ADENOSINE RECEPTOR MODULATORS<br/>[FR] MODULATEURS DE RECEPTEURS DE L'ADENOSINE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2001062233A2

  公开（公告）日：2001-08-30

  The invention relates to cyclic heteroaromatic compounds, containing at least one nitrogen atom, and to their use in the manufacture of medicaments for the treatment of diseases, related to adenosine receptor modulators, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain, respiration deficits, depression, asthma, allergic responses, hypoxia, ischaemia, seizure, substance abuse, sedation and they may be active as muscle relaxants, antipsychotics, antiepileptics, anticonvulsants and cardioprotective agents.